Beschreibung

Lagevrio – Oral Antiviral for COVID-19 (Rx)

Lagevrio (molnupiravir) is an oral antiviral medication used for the treatment of mild to moderate COVID-19 in adults who are at high risk of progressing to severe disease. It is a nucleoside analog antiviral that works by introducing errors into the viral RNA during replication, a process known as viral “error catastrophe”, which reduces the ability of the virus to multiply.

buy Lagevrio without prescription

We sell over-the-counter Lagevrio medicine; Medikamente ohne Rezept kaufen
schnelle, diskrete und vertrauenswürdige Lieferung
schnelle und sichere Zahlung
diskret ohne Spuren einkaufen

It is not intended for hospitalized patients requiring oxygen support and is most effective when started early in the course of infection.

Wichtige Details

• Active Ingredient: Molnupiravir
• Brand Name: Lagevrio
• Drug Class: Antiviral (ribonucleoside analog)
• Indication: Mild–moderate COVID-19 in high-risk adults
• Mechanism of Action: Induces viral RNA replication errors → inhibits SARS-CoV-2 replication
• Route: Oral capsule
• Verschreibungsstatus: Rezeptpflichtiges Arzneimittel

Spezifikationen

• Dosage Form: Capsules
• Common Strength: 200 mg capsules
• Standard Dose: 800 mg (4 capsules) twice daily
• Treatment Duration: 5 days
• Administration: Oral, with or without food
• Onset of Action: Works during early viral replication phase
• Metabolism: Hydrolyzed to active form (N-hydroxycytidine)
• Excretion: Primarily renal
• Lagerung: Raumtemperatur

Dosierung & Verabreichung

• Take 4 capsules twice daily for 5 days
• Must be started as soon as possible after diagnosis and within early symptom onset (typically within 5 days)
• Complete the full course even if symptoms improve
• Capsules should be swallowed whole

Kompatibilität / Geeignete Verwendung

• Adults with mild to moderate COVID-19
• Patients at high risk of progression (e.g., older age, chronic disease, immunocompromised)
• Outpatient or early-stage treatment setting
• Not used as a substitute for vaccination

Nebenwirkungen

• Common: Diarrhea, nausea, dizziness, headache
• Rare: Allergic reactions
• Generally considered well tolerated in short-course use

Why Choose Lagevrio?

Lagevrio provides a simple oral 5-day antiviral regimen for early treatment of COVID-19 in high-risk patients. Its mechanism targets viral replication directly, helping reduce the risk of severe disease when used promptly after symptom onset.